19.28
-0.24 (-1.23%)
-0.24 (-1.23%)
Upgrade to Real-Time
Afterhours (Closed)
Low
19.20
High
58.72
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Acadia Pharmaceuticals Inc | ACAD | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.24 | -1.23% | 19.28 | 19:59:49 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 19.42 | 19.20 | 19.749 | 19.40 | 19.52 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 19.27 | 19.28 | 0.01 | 1 | 3 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 17,146 | 1,786,507 | $ 19.41 | $ 34,672,490 | 2,497,018 | 19.20 - 58.72 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:49 | formt | 100 | $ 19.28 | USD |
Acadia Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 3.09B | 160.18M | 98.68M | $ 441.76M | $ -243.14M | -1.80 | -11.40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 50.22k | 0.40% |
Acadia Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ACAD Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 21.16 | 21.22 | 19.20 | 20.25 | 1,498,562 | -1.88 | -8.88% |
| 1 Month | 20.41 | 21.775 | 19.20 | 20.81 | 2,084,071 | -1.13 | -5.54% |
| 3 Months | 50.45 | 52.799 | 19.20 | 26.63 | 2,621,474 | -31.17 | -61.78% |
| 6 Months | 46.40 | 57.46 | 19.20 | 34.15 | 1,724,710 | -27.12 | -58.45% |
| 1 Year | 46.87 | 58.72 | 19.20 | 39.34 | 1,554,301 | -27.59 | -58.86% |
| 3 Years | 17.77 | 58.72 | 12.77 | 30.54 | 1,768,519 | 1.51 | 8.5% |
| 5 Years | 27.89 | 58.72 | 12.77 | 30.10 | 1,872,614 | -8.61 | -30.87% |
Acadia Pharmaceuticals Description
| Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology. |
